SharpePoint’s FS KKR Capital FSK Stock Holding History

SharpePoint’s Portfolio FSK Stock Details FSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42,475	Closed	-$634K	–	86
2025 Q3	$634K	Buy	42,475 +1,268	+3%	+$24K	0.57%	40
2025 Q2	$855K	Buy	41,207 +4,592	+13%	+$93.6K	0.88%	40
2025 Q1	$737K	Buy	36,615 +5,452	+17%	+$122K	0.65%	50
2024 Q4	$677K	Buy	+31,163	New	+$654K	0.61%	44

Other funds holding FSK

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

GAM

Generali Asset Management Trieste, Italy $5.53B AUM 35.1% 1-Year Est. Return

CWA

Cura Wealth Advisors Chicago, Illinois $234M AUM 5.19% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

DCP

Diameter Capital Partners New York $1.24B AUM 137.67% 1-Year Est. Return

SharpePoint's FSK Position: Q4 2025 in Review

SharpePoint sold out of FS KKR Capital (FSK) in Q4 2025, closing a stake of 42,475 shares — an estimated $634K sold.

SharpePoint first reported a position in FSK in Q4 2024 and held it in 4 quarters. The position peaked at $855K in Q2 2025. 498 funds tracked by Wall St. Rank hold FSK as of Q4 2025.

SharpePoint reported no remaining FS KKR Capital position as of Q4 2025 after selling out during the quarter.
SharpePoint sold 42,475 FS KKR Capital shares in Q4 2025, an estimated $634K.
SharpePoint first reported a position in FS KKR Capital in Q4 2024 and held it in 4 quarters.
SharpePoint's FS KKR Capital position peaked at $855K in Q2 2025.
498 funds tracked by Wall St. Rank held FS KKR Capital as of Q4 2025.

Based on SharpePoint's 13F filing for Q4 2025, filed 11 Feb 2026.